BOCCON-GIBOD ET AL: "Optimising Hormone Therapy in Advanced Disease" EUROPEAN UROLOGY SUPPLEMENTS, XX, XX, vol. 4, no. 8, 1 November 2005 (2005-11-01), pages 21-29, XP005112815 ISSN: 1569-9056 (B1)

VAN POPPEL H ET AL: "A ONE-YEAR, MULTICENTRE, RANDOMISED STUDY OF DEGARELIX, A GONADATROPHIN-RELEASING HORMONE (GNRH) RECEPTOR BLOCKER, IN PROSTATE CANCER PATIENTS", EUROPEAN UROLOGY SUPPLEMENTS, XX, XX, vol. 5, no. 2, 1 April 2006 (2006-04-01), page 251, XP027981205, ISSN: 1569-9056 [retrieved on 2006-04-01] (B1)

BRACARDA S ET AL: "Cancer of the prostate", CRITICAL REVIEWS IN ONCOLOGY / HEMATOLOGY, ELSEVIER SCIENCE IRELAND LTD., LIMERICK, IE, vol. 56, no. 3, 1 December 2005 (2005-12-01), pages 379-396, XP027789956, ISSN: 1040-8428 [retrieved on 2005-12-01] (B1)

DEBRUYNE FRANS M J: "Gonadotropin-releasing hormone antagonist in the management of prostate cancer." REVIEWS IN UROLOGY 2004, vol. 6 Suppl 7, 2004, pages S25-S32, XP002527257 ISSN: 1523-6161 (B1)

DEGARELIX STUDY GROUP TAMMELA ET AL: "904Degarelix - a phase 11 multicentre, randomized dose-escalating study testing a novel gnrh receptor blocker in prostate cancer patients" EUROPEAN UROLOGY SUPPLEMENTS, XX, XX, vol. 4, no. 3, 1 March 2005 (2005-03-01), page 228, XP005007365 ISSN: 1569-9056 (B1)

DOEHN CHRISTIAN ET AL: "Drug evaluation: Degarelix--a potential new therapy for prostate cancer." IDRUGS : THE INVESTIGATIONAL DRUGS JOURNAL AUG 2006, vol. 9, no. 8, August 2006 (2006-08), pages 565-572, XP009105353 ISSN: 1369-7056 (B1)

GITTELMAN ET AL: "MP-08.21: A multicentre, randomised one year dose-finding study of degarelix, a gonadotrophin-releasing hormone (GnRH) receptor blocker, in prostate cancer patients" UROLOGY, BELLE MEAD, NJ, US, vol. 70, no. 3, 1 September 2007 (2007-09-01), pages 83-84, XP022248654 ISSN: 0090-4295 (B1)

GONZALEZ-BARCENA D ET AL: "Luteinizing hormone-releasing hormone antagonist cetrorelix as primary single therapy in patients with advanced prostatic cancer and paraplegia due to metastatic invasion of spinal cord." UROLOGY FEB 1995, vol. 45, no. 2, February 1995 (1995-02), pages 275-281, XP002527258 ISSN: 0090-4295 (B1)

HUIRNE J A ET AL: "Gonadotropin-releasing-hormone-receptor antagonists" LANCET THE, LANCET LIMITED. LONDON, GB, vol. 358, no. 9295, 24 November 2001 (2001-11-24), pages 1793-1803, XP004805574 ISSN: 0140-6736 (B1)

IVERSEN ET AL: "MP-08.18" UROLOGY, BELLE MEAD, NJ, US, vol. 68, 1 November 2006 (2006-11-01), page 102, XP005709326 ISSN: 0090-4295 (B1)

KLOTZ LAURENCE ET AL: "The efficacy and safety of degarelix: a 12-month, comparative, randomized, open-label, parallel-group phase III study in patients with prostate cancer.", BJU INTERNATIONAL DEC 2008, vol. 102, no. 11, December 2008 (2008-12), pages 1531-1538, ISSN: 1464-410X (B1)

MONGIAT-ARTUS P ET AL: "Role of Luteinising Hormone Releasing Hormone (LHRH) Agonists and Hormonal Treatment in the Management of Prostate Cancer" EUROPEAN UROLOGY SUPPLEMENTS, XX, XX, vol. 4, no. 5, 1 July 2005 (2005-07-01), pages 4-13, XP004926296 ISSN: 1569-9056 (B1)

SORBERA L A ET AL: "Degarelix acetate. GnRH antagonist, prostate cancer therapy.", DRUGS OF THE FUTURE, vol. 31, no. 9, September 2006 (2006-09), pages 755-766, XP002548773, ISSN: 0377-8282 (B1)

VAN POPPEL H ET AL: "23 LONG-TERM EVALUATION OF DEGARELIX, A GONADOTROPHIN-RELEASING HORMONE (GNRH) RECEPTOR BLOCKER, INVESTIGATED IN A MULTICENTRE RANDOMISED STUDY IN PROSTATE CANCER (CAP) PATIENTS" EUROPEAN UROLOGY SUPPLEMENTS, XX, XX, vol. 6, no. 2, 1 March 2007 (2007-03-01), page 28, XP022686644 ISSN: 1569-9056 [retrieved on 2007-03-01] (B1)

BOYLE ET AL: "Treatment of hormone sensitive prostate cancer" EUROPEAN JOURNAL OF CANCER. SUPPLEMENT, PERGAMON, OXFORD, GB, vol. 3, no. 3, 1 October 2005 (2005-10-01), pages 331-338, XP005130027 ISSN: 1359-6349 (B1)